Kidney and liver fat accumulation: from imaging to clinical consequences

[1] Saklayen MG(2018)The global epidemic of the metabolic syndrome Curr Hypertens Rep 20 12-653

[2] Blüher M(2020)Metabolically healthy obesity Endocr Rev 28 637-338

[3] Dietrich P(2014)Non-alcoholic fatty liver disease, obesity and the metabolic syndrome Best Pract Res Clin Gastroenterol 52 329-4586

[4] Hellerbrand C(2022)Fatty kidney: a possible future for chronic kidney disease research Eur J Clin Investig 10 786-814

[5] Kanbay M(2022)Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver J Clin Transl Hepatol 23 4574-97

[6] Copur S(2022)Metabolic syndrome: updates on pathophysiology and management in 2021 Int J Mol Sci 24 807-e830

[7] Demiray A(2018)Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts Curr Pharm Des 52 87-679

[8] Sag AA(2022)Future of kidney imaging: functional magnetic resonance imaging and kidney disease progression Eur J Clin Investig 89 e826-480

[9] Covic A(2009)Adipose tissue distribution is different in type 2 diabetes Am J Clin Nutr 21 669-76

[10] Ortiz A(2011)The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 85 469-701

[1] Saklayen MG(2018)The global epidemic of the metabolic syndrome Curr Hypertens Rep 20 12-653

[2] Blüher M(2020)Metabolically healthy obesity Endocr Rev 28 637-338

[3] Dietrich P(2014)Non-alcoholic fatty liver disease, obesity and the metabolic syndrome Best Pract Res Clin Gastroenterol 52 329-4586

[4] Hellerbrand C(2022)Fatty kidney: a possible future for chronic kidney disease research Eur J Clin Investig 10 786-814

[5] Kanbay M(2022)Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver J Clin Transl Hepatol 23 4574-97

[6] Copur S(2022)Metabolic syndrome: updates on pathophysiology and management in 2021 Int J Mol Sci 24 807-e830

[7] Demiray A(2018)Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts Curr Pharm Des 52 87-679

[8] Sag AA(2022)Future of kidney imaging: functional magnetic resonance imaging and kidney disease progression Eur J Clin Investig 89 e826-480

[9] Covic A(2009)Adipose tissue distribution is different in type 2 diabetes Am J Clin Nutr 21 669-76

[10] Ortiz A(2011)The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis Eur Radiol 85 469-701